EnPlusOne is on a mission to bring RNA and RNA solutions to the world. Its ezRNA™ synthesis platform is a stepwise innovation that can incorporate a diverse array of nucleotide modifications and promises a manufacturing process that can sustainably deliver therapeutic RNA at commercial scales. In addition to direct RNA synthesis, EnPlusOne's ezRNA™ platform supports a vast array of RNA solution applications. For more information, please visit www.enplusonebio.com
Location: United States, Massachusetts, Watertown
Member count: 1-10
Total raised: $12M
Investors 1
Date | Name | Website |
09.10.2022 | Breakout V... | breakout.v... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
30.09.2022 | Seed | $12M | - | finsmes.co... |
Mentions in press and media 2
Date | Title | Description | Category | Author | Source |
30.09.2022 | EnPlusOne ... | EnPlusOne Biosciences, a Water... | USA | - | finsmes.co... |
- | EnPlusOne ... | “Homepage - EnPlusOne Bio” | - | - | fastfounde... |